Amex Global Business Travel agrees to $5.3bn deal with Apollo SPAC, Carlyle invests in GTCR-backed Resonetics

The merger includes $335 million private investment in public equity (PIPE) financing from new investors; the Carlyle deal continues the firm's focus on medical products businesses.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this